Literature DB >> 15897996

Identification of the optimal structure required for a Shiga toxin neutralizer with oriented carbohydrates to function in the circulation.

Kiyotaka Nishikawa1, Koji Matsuoka, Miho Watanabe, Katsura Igai, Kumiko Hino, Ken Hatano, Akihiro Yamada, Nobuhisa Abe, Daiyo Terunuma, Hiroyoshi Kuzuhara, Yasuhiro Natori.   

Abstract

Shiga toxin (Stx) is a major virulence factor of Stx-producing Escherichia coli. Recently, we developed a therapeutic Stx neutralizer with 6 trisaccharides of globotriaosyl ceramide, a receptor for Stx, in its dendrimer structure (referred to as "SUPER TWIG [1]6") to function in the circulation. Here, we determined the optimal structure of SUPER TWIG for it to function in the circulation and identified a SUPER TWIG with 18 trisaccharides, SUPER TWIG (2)18, as another potent Stx neutralizer. SUPER TWIGs (1)6 and (2)18 shared a structural similarity, a dumbbell shape in which 2 clusters of trisaccharides were connected via a linkage with a hydrophobic chain. The dumbbell shape was found to be required for formation of a complex with Stx that enables efficient uptake and degradation of Stx by macrophages and, consequently, for potent Stx-neutralizing activity in the circulation. We also determined the binding site of the SUPER TWIGs on Stx.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15897996     DOI: 10.1086/430388

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

1.  Identification of a wide range of motifs inhibitory to shiga toxin by affinity-driven screening of customized divalent peptides synthesized on a membrane.

Authors:  Mihoko Kato; Miho Watanabe-Takahashi; Eiko Shimizu; Kiyotaka Nishikawa
Journal:  Appl Environ Microbiol       Date:  2014-12-01       Impact factor: 4.792

2.  Identification of a peptide-based neutralizer that potently inhibits both Shiga toxins 1 and 2 by targeting specific receptor-binding regions.

Authors:  Kazue Tsutsuki; Miho Watanabe-Takahashi; Yasuaki Takenaka; Eiji Kita; Kiyotaka Nishikawa
Journal:  Infect Immun       Date:  2013-04-01       Impact factor: 3.441

Review 3.  Design and creativity in synthesis of multivalent neoglycoconjugates.

Authors:  Yoann M Chabre; René Roy
Journal:  Adv Carbohydr Chem Biochem       Date:  2010       Impact factor: 12.200

Review 4.  Shiga Toxin (Stx) Classification, Structure, and Function.

Authors:  Angela R Melton-Celsa
Journal:  Microbiol Spectr       Date:  2014-08

5.  Structure-dependent pseudoreceptor intracellular traffic of adamantyl globotriaosyl ceramide mimics.

Authors:  Mitsumasa Saito; Murugespillai Mylvaganum; Patty Tam; Anton Novak; Beth Binnington; Clifford Lingwood
Journal:  J Biol Chem       Date:  2012-03-14       Impact factor: 5.157

Review 6.  Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.

Authors:  Andreas Bauwens; Josefine Betz; Iris Meisen; Björn Kemper; Helge Karch; Johannes Müthing
Journal:  Cell Mol Life Sci       Date:  2012-07-06       Impact factor: 9.261

7.  The serine 31 residue of the B subunit of Shiga toxin 2 is essential for secretion in enterohemorrhagic Escherichia coli.

Authors:  Takeshi Shimizu; Satomi Kawakami; Toshio Sato; Terumi Sasaki; Masato Higashide; Takashi Hamabata; Toshiko Ohta; Masatoshi Noda
Journal:  Infect Immun       Date:  2007-02-26       Impact factor: 3.441

8.  Evaluation of Fab and F(ab')2 fragments and isotype variants of a recombinant human monoclonal antibody against Shiga toxin 2.

Authors:  Donna E Akiyoshi; Abhineet S Sheoran; Curtis M Rich; L Richard; Susan Chapman-Bonofiglio; Saul Tzipori
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

Review 9.  Escherichia coli O157: what every internist and gastroenterologist should know.

Authors:  Mary F Bavaro
Journal:  Curr Gastroenterol Rep       Date:  2009-08

10.  Structural analysis of the interaction between Shiga toxin B subunits and linear polymers bearing clustered globotriose residues.

Authors:  Miho Watanabe; Katsura Igai; Koji Matsuoka; Atsushi Miyagawa; Toshiyuki Watanabe; Ryohei Yanoshita; Yuji Samejima; Daiyo Terunuma; Yasuhiro Natori; Kiyotaka Nishikawa
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.